|
Longitudinal Change in Memory Performance as a Strong Endophenotype for Alzheimer’s – Archer, et al, 2023 (via DSS) |
|
|
|
|
eGWAS Mayo |
|
|
|
|
IGAP Summary Statistics- Lambert et al. (2013) |
|
|
|
|
Genome-wide summary statistics for cognitively defined late-onset Alzheimer’s disease subgroups |
|
|
|
|
CSF Summary Statistics- Cruchaga et al. (2013) |
|
|
|
|
Immune-related genetic enrichment in FTD summary statistics- Broce et al. 2018 |
|
|
|
|
Sex-specific genetic architecture of late-life memory performance (via DSS) |
|
|
|
|
Functional Annotation of genomic variants in studies of LOAD |
|
|
|
|
Safety and pharmacokinetics of a highly bioavailable resveratrol preparation(JOTROL TM) (via DSS) |
|
|
|
|
Multi-cohort study of endo-lysosomal system genetics and dementia |
|
|
|
|
Episodic Memory Trajectories (EMTs) of 13,037 elderly |
|
|
|
|
Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease – Eissman et al., 2022 (via DSS) |
|
|
|
|
ADGC Summary Statistics- Naj et al. (2011) |
|
|
|
|
IGAP Rare Variant Summary Statistics- Kunkle et al. (2019) |
|
|
|
|
Genetic architecture of subcortical brain structures in 38,851 individuals summary statistics- Satizabal et al. 2019 |
|
|
|
|
Alzheimer's disease (AD) and immune receptor recombinations (via DSS) |
|
|
|
|
ADGC African American Summary Statistics- Reitz et al. (2013) |
|
|
|
|
ADGC case-control summary statistics on 7050 samples not included in the IGAP-2013 discovery stage- Hu et al. (2019) |
|
|
|
|
Exome-wide age-of-onset analysis reveals exonic variants in ERN1 and SPPL2C associated with Alzheimer's disease |
|
|
|
|
Prediction of Psychosis in Alzheimer Disease Summary Statistics - DeMichele-Sweet, et. al. 2021 |
|
|
|
